India has released new national health accounts showing that households’ direct payments made up 42.7% of total healthcare expenditure in 2023–24, down from 43.4% in the previous financial year.
The National Health Accounts Estimates for India 2023–24 were released on 15 November. The fall of 0.7 percentage points marks a change in how the country’s health spending was financed, rather than proof that every family paid less for treatment.
Households still spent ₹406,197 crore directly on healthcare during the year. Average out-of-pocket expenditure per person rose from ₹2,767 in 2022–23 to ₹2,901 in 2023–24 in nominal terms. Those figures have not been adjusted for inflation, and they describe a national average rather than the bill faced by a particular patient.
A smaller share does not mean smaller bills
Total health expenditure reached ₹952,122 crore. That total includes both day-to-day healthcare spending and capital expenditure, such as investment in buildings and equipment, across government and private sources.
Current health expenditure, which excludes capital investment, stood at ₹837,175 crore. Capital expenditure accounted for the remaining ₹114,947 crore. The distinction matters when comparing the headline percentages: household direct payments represented 42.7% of total expenditure but about 48.5% of current expenditure.
Out-of-pocket spending means payments made directly by households when receiving healthcare. It is narrower than the measure of household health expenditure that also includes contributions to insurance. The new accounts therefore do not describe all household healthcare costs through a single percentage.
A declining direct-payment share can occur alongside an increase in the amount households spend. The latest per-person figures illustrate that distinction. They also leave open how costs varied between regions, income groups and people with different treatment needs.
Government spending and primary care
Government health expenditure, including capital investment, was ₹414,196 crore in 2023–24. It represented 43.5% of total health expenditure and 1.43% of gross domestic product. Government spending averaged ₹2,959 per person.
The government’s share of total health expenditure was slightly lower than the 43.7% recorded in 2022–23. Its much larger contribution compared with a decade earlier should not be confused with an uninterrupted annual rise in that share.
State governments accounted for about 68% of government health expenditure, with the Union government contributing about 32%. The balance underlines the substantial role of state-level financing within India’s health system.
Government spending on primary healthcare reached approximately ₹1.53 lakh crore. Primary care accounted for 51% of government current health expenditure, a measure that excludes capital spending. The classification covers preventive services and general outpatient care, alongside associated medicines and diagnostics, rather than spending only at facilities labelled primary health centres.
Social security expenditure on health increased from 9.9% to 11% of total health expenditure between 2022–23 and 2023–24. This category includes government-financed insurance, social health insurance and healthcare benefits or reimbursements for government employees. Private health insurance expenditure rose separately from 9.2% to 10.2% of the total.
Reading the decade-long comparison
Across the longer period, government health expenditure increased from ₹129,778 crore in 2013–14 to ₹414,196 crore in 2023–24. These are nominal monetary amounts, so the comparison is not a measure of growth after inflation. Over the same period, household out-of-pocket expenditure fell from 64.2% to 42.7% of total spending.
The latest accounts are the eleventh round prepared by the National Health Accounts Technical Secretariat at the National Health Systems Resource Centre. They use the internationally recognised System of Health Accounts 2011 framework to organise spending by financing arrangements, providers and services.
The accounts measure financial flows, not individual clinical outcomes. They do not establish that a particular government programme caused the changing spending balance, that treatment quality improved everywhere or that every household gained financial protection. Their central contribution is a more detailed picture of who financed healthcare in 2023–24, while keeping the scale of direct household payments visible.